News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,129 Results
Type
Article (41590)
Company Profile (307)
Press Release (693216)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (207151)
Career Advice (2041)
Deals (35880)
Drug Delivery (125)
Drug Development (82536)
Employer Resources (175)
FDA (16520)
Job Trends (15106)
News (350519)
Policy (32953)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2598)
Accelerated approval (43)
Adcomms (25)
Allergies (165)
Alliances (50231)
ALS (196)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (390)
Approvals (16866)
Artificial intelligence (611)
Autoimmune disease (237)
Automation (52)
Bankruptcy (362)
Best Places to Work (11737)
BIOSECURE Act (20)
Biosimilars (210)
Biotechnology (205)
Bladder cancer (180)
Brain cancer (67)
Breast cancer (697)
Cancer (5445)
Cardiovascular disease (463)
Career advice (1728)
Career pathing (41)
CAR-T (307)
CDC (54)
Celiac Disease (2)
Cell therapy (816)
Cervical cancer (43)
Clinical research (71239)
Collaboration (1975)
Company closure (4)
Compensation (1315)
Complete response letters (74)
COVID-19 (2740)
CRISPR (99)
C-suite (1032)
Cystic fibrosis (151)
Data (7215)
Decentralized trials (3)
Denatured (26)
Depression (157)
Dermatology (69)
Diabetes (553)
Diagnostics (6864)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (301)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (267)
Earnings (92087)
Editorial (62)
Employer branding (22)
Employer resources (154)
Events (120769)
Executive appointments (1061)
FDA (20031)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1650)
Gene editing (213)
Generative AI (54)
Gene therapy (658)
GLP-1 (1035)
Government (4721)
Grass and pollen (7)
Guidances (400)
Healthcare (19007)
HIV (77)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (277)
Immuno-oncology (86)
Indications (164)
Infectious disease (3064)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (278)
Interviews (320)
IPO (16838)
IRA (50)
Job creations (3693)
Job search strategy (1439)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (560)
Leadership (35)
Legal (7978)
Liver cancer (98)
Longevity (30)
Lung cancer (726)
Lymphoma (413)
Machine learning (54)
Management (59)
Manufacturing (958)
MASH (182)
Medical device (13884)
Medtech (13965)
Mergers & acquisitions (20225)
Metabolic disorders (1433)
mRNA (177)
Multiple sclerosis (179)
NASH (17)
Neurodegenerative disease (388)
Neuropsychiatric disorders (97)
Neuroscience (3188)
Neurotech (1)
NextGen: Class of 2026 (6548)
Non-profit (4540)
Now hiring (74)
Obesity (674)
Opinion (279)
Ovarian cancer (196)
Pain (236)
Pancreatic cancer (263)
Parkinson's disease (348)
Partnered (33)
Patents (564)
Patient recruitment (622)
Peanut (60)
People (60043)
Pharmaceutical (70)
Pharmacy benefit managers (32)
Phase 1 (22227)
Phase 2 (31417)
Phase 3 (23269)
Pipeline (7433)
Policy (305)
Postmarket research (2572)
Preclinical (9437)
Press Release (64)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (319)
Rare diseases (1007)
Real estate (6050)
Recruiting (71)
Regulatory (25252)
Reports (54)
Research institute (2422)
Resumes & cover letters (353)
Rett syndrome (33)
RNA editing (17)
RSV (87)
Schizophrenia (169)
Series A (271)
Series B (206)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3673)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (60)
Vaccines (1072)
Venture capital (100)
Weight loss (431)
Women's health (113)
Worklife (20)
Date
Today (145)
Last 7 days (579)
Last 30 days (2648)
Last 365 days (30339)
2026 (8992)
2025 (30428)
2024 (35557)
2023 (40472)
2022 (51633)
2021 (56244)
2020 (54470)
2019 (46898)
2018 (35313)
2017 (32506)
2016 (31947)
2015 (38017)
2014 (31842)
2013 (26766)
2012 (28940)
2011 (29608)
2010 (27666)
Location
Africa (748)
Alabama (96)
Alaska (7)
Arizona (335)
Arkansas (15)
Asia (40492)
Australia (6580)
California (12477)
Canada (3578)
China (1289)
Colorado (539)
Connecticut (538)
Delaware (376)
Europe (88204)
Florida (1905)
Georgia (400)
Hawaii (3)
Idaho (62)
Illinois (986)
India (84)
Indiana (574)
Iowa (22)
Japan (504)
Kansas (129)
Kentucky (46)
Louisiana (39)
Maine (75)
Maryland (1510)
Massachusetts (8982)
Michigan (348)
Minnesota (686)
Mississippi (6)
Missouri (141)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3335)
New Mexico (29)
New York (3312)
North Carolina (1644)
North Dakota (8)
Northern California (6184)
Ohio (373)
Oklahoma (23)
Oregon (42)
Pennsylvania (2525)
Puerto Rico (29)
Rhode Island (50)
South America (1125)
South Carolina (81)
South Dakota (2)
Southern California (4905)
Tennessee (200)
Texas (1977)
United States (44424)
Utah (373)
Vermont (1)
Virginia (300)
Washington D.C. (80)
Washington State (1019)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
735,129 Results for "regenerx biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XTL Biopharmaceuticals Announces ADS Ratio Change
March 23, 2026
·
4 min read
Press Releases
Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors
February 2, 2026
·
3 min read
Press Releases
Sino Biological ProPure™ Endotoxin-Free Proteins: The “Invisible Guardian” of Biopharmaceuticals
April 1, 2026
·
2 min read
Press Releases
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
April 6, 2026
·
4 min read
Press Releases
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
March 31, 2026
·
7 min read
Press Releases
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
April 2, 2026
·
5 min read
Press Releases
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
March 26, 2026
·
6 min read
Press Releases
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors
March 5, 2026
·
4 min read
BioCapital
RegeneRx To Extend Consent Solicitation Vote
RegeneRx Biopharmaceuticals, Inc. announced that, pursuant to the company’s consent solicitation dated July 11, 2023, holders of 48.5% of the Company’s outstanding stock have voted to date, with 94% voting in favor of the proposed reverse stock split.
August 1, 2023
·
2 min read
Press Releases
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026
·
5 min read
1 of 73,513
Next
